CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 14, 2005--ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) will hold a live webcast of a conference call at 11:00 a.m. (EST) on Wednesday, November 16, 2005. Harvey J. Berger, M.D., chairman and chief executive officer, will host the call. Senior management will discuss clinical results of its novel mTOR inhibitor, AP23573, which are being presented at 17th Annual AACR-NCI-EORTC (ANE) International Conference on “Molecular Targets and Cancer Therapeutics” in Philadelphia, Pennsylvania. The Company will announce the highlights of these data in a press release to be issued on November 16, 2005 at 10 a.m.